On March 29, 2007 the FDA announced the withdrawal of pergolide from the market, placing the health and well being of all horses diagnosed with Equine Cushing's Disease (pituitary pars intermedia dysfunction or PPID) in jeopardy.
Thanks to those who contributed their time and efforts, the continued availability of pergolide is ensured in the U.S. - for now. (See the May 11 FDA/CVM announcement.)
Sunday, April 29, 2007
New Media Contact Links Added
Check the Media Links for new contacts added. If you know of others that should be added, let us know in a comment here.